Ablynx

@AblynxABLX

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies® for a range of serious human diseases.

Ghent/Zwijnaarde, Belgium
ablynx.com
Tilmeldt maj 2012
5 billeder og videoer Billeder og videoer

Tweets

Du blokerede @AblynxABLX

Er du sikker på, at du vil vise disse Tweets? At vise Tweets vil ikke fjerne blokering af @AblynxABLX

  1. retweetede
    26. jul.

    FDA designates top nanobody caplacizumab fast track designation: 6-10 months faster approval

    3 retweets 4 likes
  2. retweetede
    20. jul.

    2.4bn "bioeuro": Belgian Nanobody delights now also tasteful in France

    2 retweets 7 likes
  3. 20. jul.

    and Sanofi to develop up to 8 Nanobody®-based therapeutics focused on immuno-inflammatory diseases

    1 svar 9 retweets 14 likes
  4. 27. jun.

    achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc.

    7 retweets 16 likes
  5. 26. jun.

    initiates a single and multiple dose Phase I study of caplacizumab in healthy Japanese subjects

    4 retweets 6 likes
  6. 29. maj

    launches , a new website dedicated to Thrombotic Thrombocytopenic Purpura (TTP)

    10 retweets 9 likes
  7. 22. maj

    receives €15M milestone from Merck KGaA for novel Nanobody in osteoarthritis

    10 retweets 12 likes
  8. 18. maj

    Meet our experts and recruiters (booth 99) @

    2 likes
  9. 11. maj

    Ablynx zit op schema via

    4 retweets 6 likes
  10. 11. maj

    Q1 2017 "Positive start of the year; good progress in multiple programmes; strong cash position"

    6 retweets 4 likes
  11. 10. maj

    Publication in Journal of Thrombosis and Haemostasis "Caplacizumab reduces major thromboembolic events"

    7 retweets 7 likes
  12. 2. maj

    successfully completes patient recruitment in its Phase III Hercules study of caplacizumab

    2 retweets 6 likes
  13. 7. apr.

    Annual Report 2016 is available online - view via

    1 retweet 4 likes
  14. 7. apr.

    - Adrianus van Herk (aandeelhouder Ablynx): 'België en Nederland zijn wereldtop' via @trends

    1 retweet 4 likes
  15. retweetede
    6. mar.

    Compelling data for developed psoriasis nanobody in collaboration

    3 retweets 2 likes
  16. retweetede
    28. feb.

    Good morning to those waking up in Europe, Africa and the Middle East! Share with us what you have planned for today!

    15 svar 51 retweets 103 likes
  17. retweetede
    24. feb.

    you will find out that is dedicated to creating new medicines which will make a real difference to society!

    1 retweet 1 like
  18. 23. feb.

    FYR 2016: significant progress in R&D pipeline; strong cash position; major catalysts in 2017.

    4 retweets 3 likes
  19. 9. feb.

    will present additional data from the Phase IIb RA combination study of vobarilizumab at the Annual CRA Meeting

    2 retweets 2 likes
  20. 6. feb.

    Ablynx files caplacizumab for ultra rare blood disorder
    6 retweets 9 likes

@AblynxABLX har ikke tweetet endnu.

Indlæsning ser ud til at tage noget tid.

Twitter kan være overbelastet eller have en midlertidig forstyrrelse. Prøv igen, eller se flere oplysninger på Twitter Status.

    Du vil måske også kunne lide

    ·